Using brain imaging to improve treatment for PTSD with TMS
Official title: Targeting the Default Mode Network: A TMS-fMRI Study
Run by Palo Alto Veterans Institute for Research · NCT05646732 · Data updated 2026-11-12
This study is testing if brain scans can help improve a treatment called rTMS for people with PTSD by finding out how it affects their brain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Palo Alto Veterans Institute for Research Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | August 2, 2023 |
| Main results expected | January 31, 2025 |
| Study ends | January 31, 2025 |
| Registry record updated | April 3, 2024 |
| Trial ID | NCT05646732 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 55 with a primary diagnosis of PTSD who can safely undergo MRI and TMS procedures.
✕Probably not a fit
Patients with significant dementia or those unable to safely undergo MRI or TMS will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on the default mode network (DMN) in patients with post-traumatic stress disorder (PTSD). By utilizing functional magnetic resonance imaging (fMRI), researchers aim to identify brain regions that change in response to rTMS, potentially leading to a personalized treatment approach for PTSD. Participants will undergo psychological assessments, MRI scans, and two TMS-fMRI sessions, with a total participation time of five to six hours. The study is conducted at VA Palo Alto and Stanford University.
Why it matters
Potential benefit: If successful, this study could lead to more effective, personalized treatments for PTSD, improving patient outcomes.
How similar studies have gone: While there have been studies targeting the DMN in other conditions, this specific approach using rTMS in PTSD is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 18 and 55 years of age * Ability to maintain a Motor Threshold (MT) with single pulse TMS * Ability to safely and comfortably undergo an MRI and TMS * Able to read, verbalize, understand, and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments. * PTSD diagnosis according to the DSM 5, as determined by the Clinician administered PTSD scale (CAPS-5) criteria. * Commitment to maintaining a stable medication regimen between the two fMRI sessions Exclusion Criteria: * Inability to safely and comfortably undergo an MRI. MRI safety will be determined by the center where MRI's are collected. * Inability to safely and comfortably undergo TMS. TMS exclusions include any history or condition that puts patients at risk. * Significant dementia as determined by the Montreal Cognitive Assessments (MoCA) * Common comorbid disorders of Veterans are allowed, but PTSD must be a primary diagnosis causing significant impairment that could not be accounted for by another diagnosis. Medical or mental health conditions that interact with or confound interpretation of PTSD symptoms and anxiety would be exclusionary. * Being in urgent need of care that would make participation impossible * Currently taking medications that increase the risk of seizure or influence hemodynamic response * Presence of any other condition that has the potential to prevent study completion and/or have a confounding effect on the interpretation of results.
Where it's running
-
VA Palo Alto
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: Allyson C Rosen, Ph.D. — PAVIR/Palo Alto VAHCS/Stanford University
- Study coordinator: James Lavacot, BA
- Email: james.lavacot@va.gov
- Phone: 6504935000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive vagus nerve stimulation (gammaCore) for PTSD
This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.
-
Non‑trauma PTSD treatment for veterans and service members with mild or moderate TBI
This pilot will test a non‑trauma psychotherapy program to help veterans and service members with mild or moderate traumatic brain injury who have PTSD.
-
Psilocybin-assisted therapy for PTSD after sexual assault
This trial will test whether a single 25 mg oral dose of psilocybin combined with therapy helps cisgender women who have PTSD from a sexual assault.
-
Short-term therapy for PTSD symptoms
This study is testing a week-long therapy to see if it can help adults with PTSD feel better and reduce their symptoms.
-
Augmented reality-enhanced exposure therapy for PTSD in U.S. military personnel
This tests whether adding augmented reality to standard exposure therapy helps U.S. military veterans and active-duty adults with PTSD.
-
Working memory training to improve fear extinction in veterans with PTSD
This study is testing if a special memory training program can help veterans with PTSD learn to manage their fears better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.